Allurion Technologies, Inc. (ALUR NYSE) stock market data APIs
$2.1337
0.01(0.5%)
as of September 17, 2025
Try our APIs with
free plan!
Allurion Technologies, Inc. Financial Data Overview
Price chart is built with
Anychart
Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform offers the Allurion Program, a swallowable and procedure-less intragastric balloon for weight loss, as well as provides access to artificial intelligence-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company operates in Spain, France, Turkey, and internationally. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.
Prev. Close
2.1337
Open
2.1464
High
2.1512
Low
2.1337
52 wk Range
1.98-20
Market Cap
16 457 K
Shares Outstanding
7 763 K
Revenue
19 917 K
EPS
-1.28
Beta
-0.498
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Allurion Technologies, Inc. data using free add-ons & libraries
Get Allurion Technologies, Inc. Fundamental Data
Allurion Technologies, Inc. Fundamental data includes:
- Net Revenue: 19 917 K
- EBITDA: -37 713 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-19
- EPS/Forecast: -0.13
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Allurion Technologies, Inc. News
New
Allurion Technologies, Inc. (ALUR) Reports Q2 Loss, Misses Revenue Estimates
Allurion Technologies, Inc. (ALUR) came out with a quarterly loss of $0.57 per share versus the Zacks Consensus Estimate of a loss of $0.65. This compares to earnings of $0.25 per share a year ago. Th...
Allurion pivots to combination therapy strategy while pursuing U.S. market launch
Earnings Call Insights: Allurion Technologies Inc. (ALUR) Q2 2025 MANAGEMENT VIEW * Shantanu K. Gaur, CEO, stated that "our new strategy doubles down on metabolically healthy weight loss, losing w...
Allurion partners with Minogue Medical to expand weight loss program in Canada
NATICK, Mass. - Allurion Technologies, Inc. (NYSE:ALUR), currently trading at $2.88 with a market capitalization of $21.33 million, announced Wednesday a distribution partnership with Minogue Medical ...
Allurion Technologies Inc. (ALUR) Returns to France with 12.2% Weight Loss, 6.6% Muscle Gain Results
Allurion Technologies Inc. (NYSE:ALUR), a leader in innovative weight loss solutions, is set to resume patient treatments in France next month following the successful resumption of product shipments....
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
